Pharma Connect Capital, established on October 10, 2017, is a venture capital firm based in Groningen, Netherlands. The firm focuses on investing in early-stage companies involved in drug development, drug delivery technologies, biomarkers, and diagnostics. It primarily supports startups located in the regions of Groningen, Friesland, and Drenthe, aiming to bridge the innovation and financing gap in the pharmaceutical industry. The fund is professionally managed by Jan Hendriks, an experienced entrepreneur with a background in the dynamic life sciences environment of Groningen. Pharma Connect Capital collaborates closely with the Pharma Portal to support young pharmaceutical initiatives in designing product development plans according to current regulatory and quality standards.
Is Pharma Connect Capital the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Pharma Connect Capital, along with a list of other relevant VCs, is available on Hopohopo.io.
Investment role
Lead and follow
Stages
Pre-seed, Seed
First ticket size
€3,000,000 - €8,000,000
When reaching out to Pharma Connect Capital, founders should highlight their alignment with regional innovation ecosystems and demonstrate a clear path to regulatory compliance and clinical validation. Emphasize how your team leverages local scientific talent and infrastructure, and be prepared to discuss your strategy for navigating early technical and regulatory milestones. Show a strong understanding of the unique challenges in pharmaceutical commercialization, and articulate how your solution addresses unmet needs in drug development or diagnostics.
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.